December 28, 2006

BATTELLE SECURES PATENT FOR ELECTRODE GEL WITH ENHANCED CONDUCTIVITY

Columbus, OH--Battelle was issued a patent recently for an innovative electrode gel designed to improve patient comfort during EEG procedures by eliminating the need for aggressive skin abrasion. The technology also may enhance the effectiveness of other diagnostic and therapeutic procedures.

The gel is formulated to rapidly permeate the skin, increasing conductivity and eliminating the need for aggressive skin preparation/abrasion for EEG testing. The gel is intended to maximize patient comfort and minimize the adverse effects of EEG testing. In addition, the conductive characteristics of the gel may enhance transdermal drug delivery and transdermal or trans-mucosal movement of body fluids for non-invasive diagnostic tests. The enhanced electrode gel technology is available for license or acquisition.

Battelle Medical Device Solutions delivers integrated engineering and life science capabilities through a comprehensive set of research and development services including applied research, device development, pre-clinical and clinical research, and sustaining engineering. Clients include medical device, biotechnology, and pharmaceutical companies serving a wide range of therapeutic and diagnostic markets.

Battelle is the world's largest non-profit independent research and development organization, with 20,000 employees in more than 120 locations worldwide, including five national laboratories Battelle manages or co-manages for the U.S. Department of Energy. Headquartered in Columbus, Ohio, Battelle conducts $3.7 billion in R&D annually through contract research, laboratory management, and technology commercialization. Battelle provides innovative solutions to some of the world's most important problems including global climate change, sustainable energy technologies, high performance materials, next generation healthcare diagnostics and therapeutics, and advanced security solutions for people, infrastructure, and the nation. Battelle has a long history of developing successful commercial products in collaboration with its clients, ranging from products to fight diabetes, cancer, and heart disease to the development of the office copier machine (Xerox). As a non-profit charitable trust with an eye toward the future, Battelle actively supports and promotes science and math education.

For more information, contact Kevin Taylor at taylorkm@battelle.org or (614) 424-5215.